JJ PHARMA CONSULT ApS: Financial statements 2019
CVR: 33257635
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -22,331 and a net result of DKK -27,282 compared with DKK -42,594 the year before. Equity in the 2019 report amounted to DKK 1,828,332. The solvency ratio was 99.3%.
- Gross Profit
- DKK -22,331
- Profit/Loss
- DKK -27,282
- Equity
- DKK 1,828,332
- Total Assets
- DKK 1,841,432
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -22 t. | -27 t. | 1.8 mio. | - |
| 2018 | - | -40 t. | -43 t. | 2 mio. | 0 |
| 2017 | - | -18 t. | 585 t. | 2.1 mio. | - |
| 2016 | - | -45 t. | 315 t. | 1.6 mio. | - |
| 2015 | - | -17 t. | 582 t. | 1.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JJ PHARMA CONSULT ApS has published its annual report for 2018. Gross profit came to DKK -40,319, and the net result was DKK -42,594.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.